.svg){kind=small}
Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
VET CBD has demonstrated a strong presence in the California market, particularly within the Tincture & Sublingual category. Consistently holding the 4th rank from September through December 2025, the brand has shown stability and resilience in maintaining its position. This consistency is complemented by a notable increase in sales, with December seeing a significant peak compared to previous months. Such performance indicates a strong brand loyalty and effective market strategy within this category in California.
In contrast, VET CBD's performance in Arizona presents a mixed picture. While the brand did not make it into the top 30 for the Edible category, indicating potential challenges or competition in this segment, it achieved a commendable 4th place ranking in the Tincture & Sublingual category by November and maintained this position in December. This suggests a strategic focus or competitive advantage in this specific category, despite overall market difficulties in other segments. The brand's ability to secure a top position in a new category could be an indicator of potential growth opportunities in Arizona's market.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in California, VET CBD has maintained a consistent rank of 4th place from September to December 2025. Despite this steady positioning, VET CBD's sales have shown a significant upward trend, culminating in a notable increase by December. This stability in rank amidst rising sales suggests a robust market presence, though it faces stiff competition from brands like Care By Design, which consistently holds the 3rd rank with slightly higher sales. Meanwhile, Papa & Barkley experienced a slight dip from 1st to 2nd rank in December, indicating potential shifts at the top. ABX / AbsoluteXtracts and Mary's Medicinals trail behind VET CBD, with Mary's Medicinals showing a promising upward trajectory in sales and rank. These dynamics highlight the competitive pressure VET CBD faces, emphasizing the importance of strategic positioning and marketing to maintain and potentially improve its market standing.
Notable Products
In December 2025, the top-performing product for VET CBD was the CBD/THC 20:1 Regular Strength Tincture (250mg CBD, 12.5mg THC, 60ml, 2oz) in the Tincture & Sublingual category, maintaining its first-place rank with sales reaching 1186 units. The CBD/THC 20:1 Regular Strength Tincture (125mg CBD, 6.25mg THC, 1oz, 30ml) held steady in the second position, with a notable increase in sales over previous months. The CBD/THC 20:1 Extra Strength Pet Tincture (250mg CBD, 25mg THC, 60ml, 2oz) improved its position to third place from the previous month's fourth rank. Meanwhile, the CBD/THC 20:1 Regular Strength Tincture (1000mg CBD, 50mg THC, 2oz, 60ml) rose to fourth place, showing a consistent upward trend in sales. The new entrant, CBD/THC 20:1 Regular Strength Tincture (500mg CBD, 25mg THC, 60ml, 2oz), debuted at fifth place, contributing to the diverse product lineup's success.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
